The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Open accessAbstract
Guidelines for the management of community-acquired pneumonia were issued on behalf of the Infectious Diseases Society of America in April 1998. The present version represents a revision of these guidelines issued in February 2000; updates at 6- to 12-month intervals are anticipated. A summary of these guidelines follows. Grading system. Recommendations are categorized by the letters A–D, according to the strength of the recommendation: A, good evidence to support the recommendation; B, moderate evidence to support the recommendation; C, poor evidence to support the recommendation; and D, evidence against the recommendation. The recommendations are also graded by the quality of the evidence to support the recommendation, on the basis of categories I–III; I, at least 1 randomized controlled trial supports the recommendation; II, evidence from at least 1 well-designed clinical trial without randomization supports the recommendation; and III, “expert opinion.” Chest radiography. Chest radiography is considered critical for establishing the diagnosis of pneumonia and for distinguishing this condition from acute bronchitis (AB), which is a common cause of antibiotic abuse. Site of care. Recommendations regarding the decision for hospitalization are based on the methodology used in the clinical prediction rule for short-term mortality, from the publications of the Pneumonia Patient Outcome Research Team (Pneumonia PORT). Patients are stratified into 5 severity classes by means of a 2-step process. Class I indicates an age <50 years, with none of 5 comorbid conditions (neoplastic disease, liver disease, congestive heart failure, cerebrovascular disease, or renal disease), normal or only mildly deranged vital signs, and normal mental status. In step 2, patients not assigned to risk class I are stratified in classes II–V on the basis of points assigned for 3 demographic variables (age, sex, and nursing home residency), 5 comorbid conditions (summarized above), 5 physical examination findings, and 7 laboratory and/or radiographic findings. Patients in risk classes I and II do not usually require hospitalization, those in risk class III may require brief hospitalization, and those in risk classes IV and V usually require hospitalization. It should be noted that social factors, such as outpatient support mechanisms and probability of adherence, are not included in this assessment. Laboratory tests. All patients thought to have pneumonia should undergo chest radiography. The following laboratory values should be determined for patients who are hospitalized: complete blood cell count and differential, serum creatinine, blood urea nitrogen, glucose, electrolytes, and liver function tests. HIV serology with informed consent should be considered, especially for persons aged 15–54 years. Oxygen saturation should be assessed. There should be 2 pretreatment blood cultures, as well as Gram staining and culture of expectorated sputum. Selected patients should have microbiological studies for tuberculosis and legionella infection. The preferred tests for detection of Legionella species are the urinary antigen assay for Legionella pneumophila serogroup 1 and culture with selective media. The rationale for performing microbiological studies to establish an etiologic diagnosis is based on attempts to improve care of the individual patient with pathogen-specific treatment; to improve care of other patients and to advance knowledge by detecting epidemiologically important organisms (Legionella, penicillin-resistant Streptococcus pneumoniae, and methicillin-resistant Staphylococcus aureus); to implement contact-tracing and antimicrobial prophylaxis in appropriate settings (such as cases of Neisseria meningitidis infection, Haemophilus influenzae type B infection, and tuberculosis); to prevent antibiotic abuse; and to reduce antibiotic expense. Antimicrobial therapy. Recommendations are provided for pathogen-specific treatment in cases in which an etiologic diagnosis is established or strongly suspected. If this information is not available initially but is subsequently reported, changing to the antimicrobial agent that is most cost-effective, least toxic, and most narrow in spectrum is encouraged. Recommendations for treating patients who require empirical antibiotic selection are based on severity of illness, pathogen probabilities, resistance patterns of S. pneumoniae (the most commonly implicated etiologic agent), and comorbid conditions. The recommendation for outpatients is administration of a macrolide, doxycycline, or fluoroquinolone with enhanced activity against S. pneumoniae. For patients who are hospitalized, the recommendation is administration of a fluoroquinolone alone or an extended-spectrum cephalosporin (cefotaxime or ceftriaxone) a Patients in the care should or in with a fluoroquinolone or other those are not may be to the patient is is and is to patients a clinical on chest usually the clinical and chest radiography
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
Self-citationInfectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Blacklow, N. R., Gorbach, S. L., & Bartlett, J. G. (1992) · Cited by 2,753
Self-citationMandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Smallpox as a Biological Weapon: Medical and Public Health Management
Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., Hauer, J., Layton, M., McDade, J., Osterholm, M. T., et al. (1999) · JAMA · doi:10.1001/jama.281.22.2127 · Cited by 1,541
Self-citationPrognosis and Outcomes of Patients With Community-Acquired Pneumonia: A Meta-analysis
Fine, M. J. (1996) · JAMA · doi:10.1001/jama.1996.03530260048030 · Cited by 1,310
Self-citationHoltzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citationTong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Lim, W. S. (2003) · Thorax · doi:10.1136/thorax.58.5.377 · Cited by 3,070
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Self-citationLegionella and Legionnaires' Disease: 25 Years of Investigation
Fields, B. S., Benson, R. F., & Besser, R. E. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.506-526.2002 · Cited by 1,601
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
Lim, W. S., Baudouin, S. V., George, R. C., Hill, A. T., Jamieson, C., Le Jeune, I., Macfarlane, J. T., Read, R. C., Roberts, H. J., Levy, M. L., et al. (2009) · Thorax · doi:10.1136/thx.2009.121434 · Cited by 1,420
Mycoplasma pneumoniae and Its Role as a Human Pathogen
Waites, K. B., & Talkington, D. F. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.697-728.2004 · Cited by 1,339
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Harris, M., Clark, J., Coote, N., Fletcher, P., Harnden, A., McKean, M., Thomson, A., & On behalf of the British Thoracic Society Standards of Care Committee (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200598 · Cited by 1,095
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
Self-citationEpidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
Calandra, T., & Cohen, J. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000168253.91200.83 · Cited by 839
Houck, P. M., Bratzler, D. W., Nsa, W., Ma, A., & Bartlett, J. G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.637 · Cited by 796
Self-citationPathogenesis, treatment, and prevention of pneumococcal pneumonia
van der Poll, T., & Opal, S. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61114-4 · Cited by 720
Musher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Self-citationManagement of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
Davies, H. E., Davies, R. J. O., Davies, C. W. H., & on behalf of the BTS Pleural Disease Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.137000 · Cited by 619
Community-Acquired Pneumonia in Children
McIntosh, K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011994 · Cited by 597
Craig, W. A. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00065-5 · Cited by 556
Charles, P. G. P., Wolfe, R., Whitby, M., Fine, M. J., Fuller, A. J., Stirling, R., Wright, A. A., Ramirez, J. A., Christiansen, K. J., Waterer, G. W., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589754 · Cited by 536
Self-citationPractice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420939 · Cited by 532
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Johansson, N., Kalin, M., Tiveljung‐Lindell, A., Giske, C. G., & Hedlund, J. (2010) · Clinical Infectious Diseases · doi:10.1086/648678 · Cited by 500
“With regard to bacteriological methods, all sputum samples were examined by microscopy, and samples containing a preponderance of leukocytes and a few squamous epithelial cells were considered acceptable for culture, according to accepted criteria [22].”
MethodHecker, M. T., Aron, D. C., Patel, N. P., Lehmann, M. K., & Donskey, C. J. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.8.972 · Cited by 495
File, T. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15021-0 · Cited by 491
Self-citationBurden of Community-Acquired Pneumonia in North American Adults
File, T. M., & Marrie, T. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.03.2130 · Cited by 472
Self-citationYu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia
Gadsby, N. J., Russell, C. D., McHugh, M. P., Mark, H., Conway Morris, A., Laurenson, I. F., Hill, A. T., & Templeton, K. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1214 · Cited by 446
Angus, D. C., Berry, S., Lewis, R. J., Al-Beidh, F., Arabi, Y., van Bentum-Puijk, W., Bhimani, Z., Bonten, M., Broglio, K., Brunkhorst, F., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202003-192sd · Cited by 446
Effectiveness of manual therapies: the UK evidence report
Bronfort, G., Haas, M., Evans, R., Leininger, B., & Triano, J. (2010) · Chiropractic & Osteopathy · doi:10.1186/1746-1340-18-3 · Cited by 434
Baddour, L. M., Yu, V. L., Klugman, K. P., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Luna, C. M., Snydman, D. R., Ko, W. C., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200311-1578oc · Cited by 438
Said, M. A., Johnson, H. L., Nonyane, B. A. S., Deloria-Knoll, M., O′Brien, K. L., & for the AGEDD Adult Pneumococcal Burden Study Team (2013) · PLoS ONE · doi:10.1371/journal.pone.0060273 · Cited by 435
Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study
Gajic, O., Rana, R., Winters, J. L., Yilmaz, M., Mendez, J. L., Rickman, O. B., O'Byrne, M. M., Evenson, L. K., Malinchoc, M., DeGoey, S. R., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-271oc · Cited by 430
Amsden, G. W. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh519 · Cited by 409
Trimethoprim-Sulfamethoxazole Revisited
Masters, P. A., O'Bryan, T. A., Zurlo, J., Miller, D. Q., & Joshi, N. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.402 · Cited by 408
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
Ewig, S., Birkner, N., Strauss, R., Schaefer, E., Pauletzki, J., Bischoff, H., Schraeder, P., Welte, T., & Hoeffken, G. (2009) · Thorax · doi:10.1136/thx.2008.109785 · Cited by 403
Acute pneumonia and the cardiovascular system
Corrales-Medina, V. F., Musher, D. M., Shachkina, S., & Chirinos, J. A. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61266-5 · Cited by 400
Self-citationInhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease
Kew, K. M., & Seniukovich, A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010115.pub2 · Cited by 398
Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong
Choi, K. W., Chau, T. N., Tsang, O., Tso, E., Chiu, M. C., Tong, W. L., Lee, P. O., Ng, T. K., Ng, W. F., Lee, K. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-9-200311040-00005 · Cited by 397
Khan, H., Belsher, J., Yilmaz, M., Afessa, B., Winters, J. L., Moore, S. B., Hubmayr, R. D., & Gajic, O. (2007) · Chest · doi:10.1378/chest.06-3048 · Cited by 382
Aujesky, D., Auble, T. E., Yealy, D. M., Stone, R. A., Obrosky, D. S., Meehan, T. P., Graff, L. G., Fine, J. M., & Fine, M. J. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.006 · Cited by 377
Self-citationAntibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
Postma, D. F., van Werkhoven, C. H., van Elden, L. J. R., Thijsen, S. F. T., Hoepelman, A. I. M., Kluytmans, J. A. J. W., Boersma, W. G., Compaijen, C. J., van der Wall, E., Prins, J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406330 · Cited by 376
Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure
Carrillo, A., Gonzalez-Diaz, G., Ferrer, M., Martinez-Quintana, M. E., Lopez-Martinez, A., Llamas, N., Alcazar, M., & Torres, A. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2475-6 · Cited by 358
Martinez, J. A., Horcajada, J. P., Almela, M., Marco, F., Soriano, A., Garcia, E., Marco, M. A., Torres, A., & Mensa, J. (2003) · Clinical Infectious Diseases · doi:10.1086/367541 · Cited by 357
Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature
Khaliq, Y., & Zhanel, G. G. (2003) · Clinical Infectious Diseases · doi:10.1086/375078 · Cited by 357
Occult hypoperfusion and mortality in patients with suspected infection
Howell, M. D., Donnino, M., Clardy, P., Talmor, D., & Shapiro, N. I. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0680-5 · Cited by 356
Gulmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 341
Moussaoui, R. E., de Borgie, C. A. J. M., van den Broek, P., Hustinx, W. N., Bresser, P., van den Berk, G. E. L., Poley, J.-W., van den Berg, B., Krouwels, F. H., Bonten, M. J. M., et al. (2006) · BMJ · doi:10.1136/bmj.332.7554.1355 · Cited by 339
High‐Dose, Short‐Course Levofloxacin for Community‐Acquired Pneumonia: A New Treatment Paradigm
Dunbar, L. M., Wunderink, R. G., Habib, M. P., Smith, L. G., Tennenberg, A. M., Khashab, M. M., Wiesinger, B. A., Xiang, J. X., Zadeikis, N., & Kahn, J. B. (2003) · Clinical Infectious Diseases · doi:10.1086/377539 · Cited by 335
Development and Validation of a Clinical Prediction Rule for Severe Community-acquired Pneumonia
España, P. P., Capelastegui, A., Gorordo, I., Esteban, C., Oribe, M., Ortega, M., Bilbao, A., & Quintana, J. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-177oc · Cited by 327
Templeton, K. E., Scheltinga, S. A., van den Eeden, W. C. J. F. M., Graffelman, W. A., van den Broek, P. J., & Claas, E. C. J. (2005) · Clinical Infectious Diseases · doi:10.1086/431588 · Cited by 325
Siemieniuk, R. A. C., Meade, M. O., Alonso-Coello, P., Briel, M., Evaniew, N., Prasad, M., Alexander, P. E., Fei, Y., Vandvik, P. O., Loeb, M., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0715 · Cited by 324
Lonks, J. R., Garau, J., Gomez, L., Xercavins, M., Ochoa de Echagüen, A., Gareen, I. F., Reiss, P. T., & Medeiros, A. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341978 · Cited by 324
Carratalà, J., Mykietiuk, A., Fernández-Sabé, N., Suárez, C., Dorca, J., Verdaguer, R., Manresa, F., & Gudiol, F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1393 · Cited by 323
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Macrolide Resistance Among Invasive <EMPH TYPE="ITAL">Streptococcus pneumoniae</EMPH> Isolates
Hyde, T. B. (2001) · JAMA · doi:10.1001/jama.286.15.1857 · Cited by 315
Angus, D. C., Marrie, T. J., Obrosky, D. S., Clermont, G., Dremsizov, T. T., Coley, C., Fine, M. J., Singer, D. E., & Kapoor, W. N. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2102084 · Cited by 314
Self-citationConcentration and Quality of Hospitals That Care for Elderly Black Patients
Jha, A. K., Orav, E. J., Li, Z., & Epstein, A. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.11.1177 · Cited by 306
Bloom, C. I., Graham, C. M., Berry, M. P. R., Rozakeas, F., Redford, P. S., Wang, Y., Xu, Z., Wilkinson, K. A., Wilkinson, R. J., Kendrick, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070630 · Cited by 304
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y.-X. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Cao, B., Huang, Y., She, D., Cheng, Q., Fan, H., Tian, X., Xu, J., Zhang, J., Chen, Y., Shen, N., et al. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12674 · Cited by 300
Trends in Legionnaires Disease, 1980–1998: Declining Mortality and New Patterns of Diagnosis
Benin, A. L., Benson, R. F., & Besser, R. E. (2002) · Clinical Infectious Diseases · doi:10.1086/342903 · Cited by 295
Metersky, M. L., Masterton, R. G., Lode, H., File, T. M., & Babinchak, T. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2012.01.003 · Cited by 293
Self-citationValidation of predictive rules and indices of severity for community acquired pneumonia
Ewig, S. (2004) · Thorax · doi:10.1136/thx.2003.008110 · Cited by 290
History and Development of Evidence‐based Medicine
Claridge, J. A., & Fabian, T. C. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-7910-1 · Cited by 289
Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
Metlay, J. P., & Fine, M. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00012 · Cited by 286
Self-citationViral Infection in Adults Hospitalized With Community-Acquired Pneumonia
Johnstone, J., Majumdar, S. R., Fox, J. D., & Marrie, T. J. (2008) · Chest · doi:10.1378/chest.08-0888 · Cited by 285
Klehmet, J., Harms, H., Richter, M., Prass, K., Volk, H. D., Dirnagl, U., Meisel, A., & Meisel, C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.044 · Cited by 281
Free and Total Cortisol Levels as Predictors of Severity and Outcome in Community-acquired Pneumonia
Christ-Crain, M., Stolz, D., Jutla, S., Couppis, O., Müller, C., Bingisser, R., Schuetz, P., Tamm, M., Edwards, R., Müller, B., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-307oc · Cited by 281
Changing Use of Antibiotics in Community-Based Outpatient Practice, 19911999
Steinman, M. A., Gonzales, R., Linder, J. A., & Landefeld, C. S. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-7-200304010-00008 · Cited by 275
Linezolid: A Review of its Use in the Management of Serious Gram-Positive Infections
Perry, C. M., & Jarvis, B. (2001) · Drugs · doi:10.2165/00003495-200161040-00008 · Cited by 275
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.
(2001) · PubMed · doi:10.1136/thorax.56.suppl_4.iv1 · Cited by 272
IPINet Investigators, Quinti, I., Soresina, A., Guerra, A., Rondelli, R., Spadaro, G., Agostini, C., Milito, C., Trombetta, A. C., Visentini, M., et al. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9511-0 · Cited by 270
Knapp, S., Wieland, C. W., van ’t Veer, C., Takeuchi, O., Akira, S., Florquin, S., & van der Poll, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3132 · Cited by 268
Type 2 Diabetes and Pneumonia Outcomes
Kornum, J. B., Thomsen, R. W., Riis, A., Lervang, H.-H., Schønheyder, H. C., & Sørensen, H. T. (2007) · Diabetes Care · doi:10.2337/dc06-2417 · Cited by 261
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
Christ-Crain, M., Morgenthaler, N. G., Stolz, D., Müller, C., Bingisser, R., Harbarth, S., Tamm, M., Struck, J., Bergmann, A., & Müller, B. (2006) · Critical Care · doi:10.1186/cc4955 · Cited by 257
Terra, C., Guevara, M., Torre, A., Gilabert, R., Fernández, J., Martín-Llahí, M., Baccaro, M. E., Navasa, M., Bru, C., Arroyo, V., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.024 · Cited by 256
Martin-Loeches, I., Lisboa, T., Rodriguez, A., Putensen, C., Annane, D., Garnacho-Montero, J., Restrepo, M. I., & Rello, J. (2010) · Intensive Care Medicine · doi:10.1007/s00134-009-1730-y · Cited by 254
Martín-Loeches, I., Sanchez-Corral, A., Diaz, E., Granada, R. M., Zaragoza, R., Villavicencio, C., Albaya, A., Cerdá, E., Catalán, R. M., Luque, P., et al. (2011) · Chest · doi:10.1378/chest.10-1396 · Cited by 203
Etiology of Community-Acquired Pneumonia in Hospitalized Patients in Chile
Díaz, A., Barria, P., Niederman, M., Restrepo, M. I., Dreyse, J., Fuentes, G., Couble, B., & Saldias, F. (2007) · Chest · doi:10.1378/chest.06-1800 · Cited by 114
Top 10 pearls for the recognition, evaluation, and management of maternal sepsis
Shields, A., de Assis, V., & Halscott, T. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004471 · Cited by 76
Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Tessmer, A., Welte, T., Schmidt-Ott, R., Eberle, S., Barten, G., Suttorp, N., & Schaberg, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00133510 · Cited by 65
Choudhury, G., Mandal, P., Singanayagam, A., Akram, A. R., Chalmers, J. D., & Hill, A. T. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03542.x · Cited by 59
Disease Severity in Patients with Simultaneous Influenza and Bacterial Pneumonia
Seki, M., Kosai, K., Yanagihara, K., Higashiyama, Y., Kurihara, S., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tashiro, T., & Kohno, S. (2007) · Internal Medicine · doi:10.2169/internalmedicine.46.6364 · Cited by 57
Vitamin C supplementation for prevention and treatment of pneumonia
Padhani, Z. A., Moazzam, Z., Ashraf, A., Bilal, H., Salam, R. A., Das, J. K., & Bhutta, Z. A. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013134.pub2 · Cited by 50
Bjarnason, A., Thorleifsdottir, G., Löve, A., Gudnason, J. F., Asgeirsson, H., Hallgrimsson, K. L., Kristjansdottir, B. S., Haraldsson, G., Baldursson, O., Kristinsson, K. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046816 · Cited by 30
Metadata
- Authors
- Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-08
- Volume
- 31
- Issue
- 2
- Pages
- 347-382
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2130141864
- Cited by
- 2,286
- References
- 158
- FWCI
- 129.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.